<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02389361</url>
  </required_header>
  <id_info>
    <org_study_id>ASTES - ZIH</org_study_id>
    <nct_id>NCT02389361</nct_id>
  </id_info>
  <brief_title>Comparison of Oral Zaldiar With Intravenous Paracetamol and Tramadol</brief_title>
  <official_title>ZIH Study : Comparison of Oral Zaldiar (Combination of Paracetamol and Tramadol) With Intravenous Paracetamol and Tramadol for Postoperative Analgesia After Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Astes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Astes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of two different regimens of analgesia after inguinal hernia repair. First, is a
      classical intravenous protocol with paracetamol and tramadol. Second is an oral protocol with
      Zaldiar (combination of paracetamol and tramadol).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of two different regimens of analgesia after inguinal hernia repair. First, is a
      classical intravenous protocol with paracetamol and tramadol. This is the classical approach.
      Second is an oral protocol with Zaldiar (combination of paracetamol and tramadol). This is
      the new approach.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Pain</measure>
    <time_frame>In recovery room</time_frame>
    <description>Difference between groups in term of analgesia (as measured by Visual Analog Scale: VAS). The VAS range are between 0 and 10. A worse outcome was defined as VAS &gt; 4. The VAS use units on a scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropathic Pain</measure>
    <time_frame>at 6 months</time_frame>
    <description>Difference between groups in term of neuropathic pain (as measured by the DN4 score). The DN4 score is a score based on the answer to 10 items. 1 point by item. Thus DN4 Score range are between 0 and 10. A worse outcome is defined as a score &gt; 3.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group Z</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postoperative Analgesia with Zaldiar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group PT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Postoperative Analgesia with Paracetamol-Tramadol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zaldiar</intervention_name>
    <description>Postoperative analgesia with oral Zaldiar (combination of tramadol and paracetamol)</description>
    <arm_group_label>Group Z</arm_group_label>
    <other_name>Oral Zaldiar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol-Tramadol</intervention_name>
    <description>Postoperative analgesia with intravenous Paracetamol and Tramadol</description>
    <arm_group_label>Group PT</arm_group_label>
    <other_name>Intravenous Paracetamol and Tramadol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients incoming for inguinal hernia repair

        Exclusion Criteria:

          -  Preoperative abuse of analgesics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Deflandre</last_name>
    <role>Study Director</role>
    <affiliation>Astes</affiliation>
  </overall_official>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2015</study_first_posted>
  <results_first_submitted>June 22, 2015</results_first_submitted>
  <results_first_submitted_qc>July 18, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 13, 2015</results_first_posted>
  <last_update_submitted>July 18, 2015</last_update_submitted>
  <last_update_submitted_qc>July 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Astes</investigator_affiliation>
    <investigator_full_name>Eric DEFLANDRE, MD, FCCP</investigator_full_name>
    <investigator_title>Eric DEFLANDRE, MD, FCCP</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group Z</title>
          <description>Postoperative Analgesia with Zaldiar
Zaldiar: Postoperative analgesia with oral Zaldiar (combination of tramadol and paracetamol)</description>
        </group>
        <group group_id="P2">
          <title>Group PT</title>
          <description>Postoperative Analgesia with Paracetamol-Tramadol
Paracetamol-Tramadol: Postoperative analgesia with intravenous Paracetamol and Tramadol</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group Z</title>
          <description>Postoperative Analgesia with Zaldiar
Zaldiar: Postoperative analgesia with oral Zaldiar (combination of tramadol and paracetamol)</description>
        </group>
        <group group_id="B2">
          <title>Group PT</title>
          <description>Postoperative Analgesia with Paracetamol-Tramadol
Paracetamol-Tramadol: Postoperative analgesia with intravenous Paracetamol and Tramadol</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.08" spread="16.42"/>
                    <measurement group_id="B2" value="62.41" spread="14.51"/>
                    <measurement group_id="B3" value="57.19" spread="15.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Belgium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Acute Pain</title>
        <description>Difference between groups in term of analgesia (as measured by Visual Analog Scale: VAS). The VAS range are between 0 and 10. A worse outcome was defined as VAS &gt; 4. The VAS use units on a scale.</description>
        <time_frame>In recovery room</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group Z</title>
            <description>Postoperative Analgesia with Zaldiar
Zaldiar: Postoperative analgesia with oral Zaldiar (combination of tramadol and paracetamol)</description>
          </group>
          <group group_id="O2">
            <title>Group PT</title>
            <description>Postoperative Analgesia with Paracetamol-Tramadol
Paracetamol-Tramadol: Postoperative analgesia with intravenous Paracetamol and Tramadol</description>
          </group>
        </group_list>
        <measure>
          <title>Acute Pain</title>
          <description>Difference between groups in term of analgesia (as measured by Visual Analog Scale: VAS). The VAS range are between 0 and 10. A worse outcome was defined as VAS &gt; 4. The VAS use units on a scale.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="1.28"/>
                    <measurement group_id="O2" value="1.74" spread="1.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neuropathic Pain</title>
        <description>Difference between groups in term of neuropathic pain (as measured by the DN4 score). The DN4 score is a score based on the answer to 10 items. 1 point by item. Thus DN4 Score range are between 0 and 10. A worse outcome is defined as a score &gt; 3.</description>
        <time_frame>at 6 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group Z</title>
          <description>Postoperative Analgesia with Zaldiar
Zaldiar: Postoperative analgesia with oral Zaldiar (combination of tramadol and paracetamol)</description>
        </group>
        <group group_id="E2">
          <title>Group PT</title>
          <description>Postoperative Analgesia with Paracetamol-Tramadol
Paracetamol-Tramadol: Postoperative analgesia with intravenous Paracetamol and Tramadol</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. DEFLANDRE Eric</name_or_title>
      <organization>ASTES</organization>
      <phone>0032477764241</phone>
      <email>eric.deflandre@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

